| Cyclooxygenases, prostanoids, and tumor progression MT Wang, KV Honn, D Nie Cancer and Metastasis Reviews 26, 525-534, 2007 | 443 | 2007 |
| K-Ras promotes tumorigenicity through suppression of non-canonical Wnt signaling MT Wang, M Holderfield, J Galeas, R Delrosario, MD To, A Balmain, ... Cell 163 (5), 1237-1251, 2015 | 209 | 2015 |
| Human pregnane X receptor and resistance to chemotherapy in prostate cancer Y Chen, Y Tang, MT Wang, S Zeng, D Nie Cancer research 67 (21), 10361-10367, 2007 | 168 | 2007 |
| Role of Rho GTPases in breast cancer Y Tang, L Olufemi, MT Wang, D Nie Front Biosci 13 (2), 759-776, 2008 | 143 | 2008 |
| Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer MT Wang, N Fer, J Galeas, EA Collisson, SE Kim, J Sharib, F McCormick Nature communications 10 (1), 3055, 2019 | 84 | 2019 |
| Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho D Nie, Y Guo, D Yang, Y Tang, Y Chen, MT Wang, A Zacharek, Y Qiao, ... Cancer research 68 (1), 115-121, 2008 | 70 | 2008 |
| Impairment of mitochondrial respiration in mouse fibroblasts byoncogenic H-RASQ61L D Yang, MT Wang, Y Tang, Y Chen, H Jiang, T Jones, K Rao, G Brewer, ... Cancer biology & therapy 9 (2), 122-133, 2010 | 57 | 2010 |
| Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15‐lipoxygenase‐2 in prostate cancer Y Tang, MT Wang, Y Chen, D Yang, M Che, KV Honn, GD Akers, ... International journal of cancer 124 (7), 1545-1551, 2009 | 41 | 2009 |
| Regulations of Tumor Microenvironment by prostaglandins JZ Nie, MT Wang, D Nie Cancers 15 (12), 3090, 2023 | 6 | 2023 |
| Cancer Stem Cells in Resistance to Cytotoxic Drugs: Implications in Chemotherapy MT Wang, H Jiang, D Boral, D Nie Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted …, 2013 | 6 | 2013 |
| The role of POU5F1B in prostate cancer H Jiang, MT Wang, D Nie Cancer Research 74 (19_Supplement), 4970-4970, 2014 | 1 | 2014 |
| Cancer cells lose their expression of lipoxygenases in order to activate pro-survival and angiogenic pathways thereby establishing successful macro-metastases D Boral, MT Wang, D Nie Cancer Research 72 (8_Supplement), 3424-3424, 2012 | 1 | 2012 |
| Abstract# 3098: Thromboxane A2 receptor (TP) in tumor cell motility and metastasis X Zhang, MT Wang, Y Tang, Y Chen, D Nie Cancer Research 69 (9_Supplement), 3098-3098, 2009 | 1 | 2009 |
| Alteration of cellular energy metabolism by oncogenic transformation D Yang, MT Wang, Y Tang, Y Chen, T Jones, G Brewer, D Nie Molecular Cancer Therapeutics 6 (11_Supplement), A84-A84, 2007 | 1 | 2007 |
| Targeting K-Ras-mediated signaling pathways and malignancy by prostratin F McCormick, W Man-Tzu US Patent 10,201,516, 2019 | | 2019 |
| Abstract B048: Activation of PKC inhibits oncogenic KRAS-driven malignancies MT Wang, J Galeas, F McCormick Molecular Cancer Therapeutics 17 (1_Supplement), B048-B048, 2018 | | 2018 |
| Regulation of macropinocytosis-dependent cell survival in pancreatic cancer cells SE Kim, MT Wang, F McCormick Cancer Research 77 (13_Supplement), 435-435, 2017 | | 2017 |
| Targeting K-Ras cancers F McCormick, MT Wang Journal of Thoracic Oncology 11 (2), S9-S10, 2016 | | 2016 |
| Oncogenic K-Ras and H-Ras differentially regulate cancer stem cell-like properties via repression of non-canonical Wnt signaling. MT Wang, J Galeas, C Ritchie, F McCormick Cancer Research 73 (8_Supplement), 2327-2327, 2013 | | 2013 |
| SOX2 inhibits Wnt driven colon cancer cell proliferation. D Boral, MT Wang, D Nie Cancer Research 73 (8_Supplement), 5006-5006, 2013 | | 2013 |
